Posaconazol
C37H42F2N8O4
700,79
3H-1,2,4-Triazol-3-one, 4-[4-[4-[4-[[5-(2,4-difluorophenyl)tetrahydro-5-(1H-1,2,4-triazol-1-ylmethyl)-3-furanyl]methoxy]phenyl]-1-piperazinyl]phenyl]-2-(1-ethyl-2-hydroxypropyl)-2,4-dihydro-, [3R-[3α(1S*,2S*),5α]]-;
4-[4-{4-(4-[{(3R,5R)-5-[(1H-1,2,4-Triazol-1-il)metil]-5-(2,4-difluorofenil)tetrahidrofuran-3-il}metoxi]fenil)piperazin-1-il}fenil]-2-((2S,3S)-2-hidroxipentan-3-il)-2,4-dihidro-3H-1,2,4-triazol-3-ona [171228-49-2]
3H-1,2,4-Triazol-3-one, 4-[4-[4-[4-[[5-(2,4-difluorophenyl)tetrahydro-5-(1H-1,2,4-triazol-1-ylmethyl)-3-furanyl]methoxy]phenyl]-1-piperazinyl]phenyl]-2-(1-ethyl-2-hydroxypropyl)-2,4-dihydro-, [3R-[3α(1S*,2S*),5α]]-;
4-[4-{4-(4-[{(3R,5R)-5-[(1H-1,2,4-Triazol-1-il)metil]-5-(2,4-difluorofenil)tetrahidrofuran-3-il}metoxi]fenil)piperazin-1-il}fenil]-2-((2S,3S)-2-hidroxipentan-3-il)-2,4-dihidro-3H-1,2,4-triazol-3-ona [171228-49-2]
DEFINICIÓN
El Posaconazol contiene no menos de 98,0% y no más de 102,0% de posaconazol (C37H42F2N8O4), calculado con respecto a la sustancia anhidra.
ESTÁNDARES DE REFERENCIA USP A LA VENTA
ER Compuesto Relacionado A de Posaconazol USPER Posaconazol USP